Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Booyeon J, Han"'
Autor:
Jian Ye, Brian A Belt, Booyeon J Han, David C Linehan, Shuyang S Qin, Bradley N Mills, Jesse Garrett-Larsen, Joseph D Murphy, Taylor P Uccello, Tara G Vrooman, Carl J Johnston, Edith M Lord, Scott A Gerber
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 7 (2022)
Background Stereotactic body radiotherapy (SBRT) has been increasingly used as adjuvant therapy in pancreatic ductal adenocarcinoma (PDAC), and induces immunogenic cell death, which leads to the release of tumor antigen and damage-associated molecula
Externí odkaz:
https://doaj.org/article/54b3ed967a784f7b9badf62aea058989
Autor:
Bradley N. Mills, Kelli A. Connolly, Jian Ye, Joseph D. Murphy, Taylor P. Uccello, Booyeon J. Han, Tony Zhao, Michael G. Drage, Aditi Murthy, Haoming Qiu, Ankit Patel, Nathania M. Figueroa, Carl J. Johnston, Peter A. Prieto, Nejat K. Egilmez, Brian A. Belt, Edith M. Lord, David C. Linehan, Scott A. Gerber
Publikováno v:
Cell Reports, Vol 29, Iss 2, Pp 406-421.e5 (2019)
Summary: Over 80% of pancreatic ductal adenocarcinoma (PDA) patients are diagnosed with non-resectable late-stage disease that lacks effective neoadjuvant therapies. Stereotactic body radiation therapy (SBRT) has shown promise as an emerging neoadjuv
Externí odkaz:
https://doaj.org/article/4e46e83b18694648a2d984f0afc1f88a
Autor:
Scott A. Gerber, David C. Linehan, Brian A. Belt, Edith M. Lord, Carl J. Johnston, Ankit P. Patel, Joseph D. Murphy, Booyeon J. Han, Tony Zhao, Bradley N. Mills, Jian Ye
Pancreatic ductal adenocarcinoma (PDAC) continues to have a dismal prognosis, in part, due to ineffective treatment strategies. The efficacy of some chemotherapies and especially radiotherapy is mediated partially by the immune system. Therefore, we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::834304e1f79187791daf99469dd0ac1c
https://doi.org/10.1158/2326-6066.c.6549813
https://doi.org/10.1158/2326-6066.c.6549813
Autor:
Scott A. Gerber, David C. Linehan, Brian A. Belt, Edith M. Lord, Carl J. Johnston, Ankit P. Patel, Joseph D. Murphy, Booyeon J. Han, Tony Zhao, Bradley N. Mills, Jian Ye
Supplemental figure 3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34382ac24ed716797c2e66ecc81fb538
https://doi.org/10.1158/2326-6066.22542153.v1
https://doi.org/10.1158/2326-6066.22542153.v1
Autor:
Scott A. Gerber, David C. Linehan, Brian A. Belt, Edith M. Lord, Carl J. Johnston, Ankit P. Patel, Joseph D. Murphy, Booyeon J. Han, Tony Zhao, Bradley N. Mills, Jian Ye
Supplemental figure legends and supplemental tables
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99f5cc41072cf1af7923dea1669c66e8
https://doi.org/10.1158/2326-6066.22542138
https://doi.org/10.1158/2326-6066.22542138
Autor:
Shuyang S. Qin, Booyeon J. Han, Alexander C. Chacon, Alexa D. Melucci, Alyssa R. Williams, Rachel Jewell, Minsoo Kim, David C. Linehan, Scott A. Gerber, Peter A. Prieto
Publikováno v:
Cancer Research. 82:1605-1605
PD-1 (programmed cell death protein-1) blockade, an immunotherapy that re-stimulates antitumor CD8 T cell response, has revolutionized the treatment of metastatic melanoma. However, the majority of melanoma patients eventually acquire therapy resista
Autor:
Joseph D Murphy, David C. Linehan, Shuyang Qin, Bradley N. Mills, Jian Ye, Brian A. Belt, Nejat K. Egilmez, Taylor P Uccello, Edith M. Lord, Booyeon J. Han, Scott A. Gerber, Peter A. Prieto, Jesse Garrett-Larsen
Publikováno v:
Immunol Invest
INTRODUCTION: The tumor-draining lymph node (TDLN) plays a role in tumor immunity. Intratumorally administered microspheres (MS) that encapsulate immunomodulatory agents have emerged as a treatment strategy capable of causing profound changes in the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5aab2770bc08f2515474ae3fc90ef47
Autor:
Peter S. Goedegebuure, Jian Ye, Brian A. Belt, Ankit A Patel, David G. DeNardo, Ryan C. Fields, Roheena Z. Panni, William G. Hawkins, Dominic E. Sanford, Ryan C Jacobs, Timothy M. Nywening, David C. Linehan, William E. Gillanders, Booyeon J. Han, Darren R. Cullinan
Publikováno v:
Gut. 67:1112-1123
ObjectiveChemokine pathways are co-opted by pancreatic adenocarcinoma (PDAC) to facilitate myeloid cell recruitment from the bone marrow to establish an immunosuppressive tumour microenvironment (TME). Targeting tumour-associated CXCR2+neutrophils (T
Autor:
Jian Ye, Bradley N. Mills, Ankit Patel, Edith M. Lord, David C. Linehan, Scott A. Gerber, Brian A. Belt, Tony Zhao, Carl J. Johnston, Joseph D Murphy, Booyeon J. Han
Publikováno v:
Cancer Immunol Res
Pancreatic ductal adenocarcinoma (PDAC) continues to have a dismal prognosis, in part, due to ineffective treatment strategies. The efficacy of some chemotherapies and especially radiotherapy is mediated partially by the immune system. Therefore, we
Autor:
Timothy M, Nywening, Brian A, Belt, Darren R, Cullinan, Roheena Z, Panni, Booyeon J, Han, Dominic E, Sanford, Ryan C, Jacobs, Jian, Ye, Ankit A, Patel, William E, Gillanders, Ryan C, Fields, David G, DeNardo, William G, Hawkins, Peter, Goedegebuure, David C, Linehan
Publikováno v:
Gut. 67(6)
Chemokine pathways are co-opted by pancreatic adenocarcinoma (PDAC) to facilitate myeloid cell recruitment from the bone marrow to establish an immunosuppressive tumour microenvironment (TME). Targeting tumour-associated CXCR2Blood, bone marrow and t